Subject: Opposition to smallpox vaccine Plan_USA Today
Date: Mon, 7 Oct 2002 16:05:27 -0400
On Sept. 28 AHRP’s Infomail questioned the ethics of a proposed pediatric smallpox vaccine trial that would expose children in Cincinnati and California to a vaccine whose safety is shrouded in controversy. Given the failing grades that public health officials got for their handling of the anthrax crisis, it is not surprising that the public is not convinced that children should be exposed to the vaccine’s risks–when the evidence does not show a clear and present danger. https://ahrp.org/infomail/0902/28.php
USA Today reports that the American Academy of Pediatrics (AAP) issued a policy statement disagreeing with administration officials: “The threat of bioterrorism is not high enough to justify preventive smallpox vaccination of children and teenagers, U.S. pediatricians say in a policy statement today.” Experts say, “Estimates on adverse reactions from the vaccine, which are based on studies in the 1960s, could be low because more Americans now have weak immune systems.”
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases said that: “it’s unknown when or even if the [children smallpox ] study will start.” Dr. Fauci indicated that experts will testify on the risks and benefits of the study for kids at a public meeting in November called by the Department of Health and Human Services, and he indicated that for the trial to go forward, the HHS secretary “will have to approve the trial.”
Smallpox vaccinations: A shot in the dark 10/07/02
By Marilyn Elias,
The threat of bioterrorism is not high enough to justify preventive smallpox vaccination of children and teenagers, U.S. pediatricians say in a policy statement today.
Mass immunizations similar to one during a smallpox outbreak in New York in April 1947 are once again a real possibility.
Vaccinations should be reconsidered if new evidence suggests bioterrorism is more likely or if safer vaccines are developed, says the American Academy of Pediatrics (AAP).
Smallpox vaccines “are not nearly as safe as other vaccinations we routinely use, and they’re for diseases that are around, unlike smallpox,” says Robert Baltimore of Yale Medical School, co-author of the policy.
The influential AAP is weighing in as the federal government considers who should be vaccinated in anticipation of a bioterrorist attack. Top federal scientists Friday recommended making vaccine available to any American who wants it after medical and emergency workers are immunized.
15 per 1,000,000 would develop life-threatening complications, such as encephalitis, after vaccination. 1 to 2 per 1,000,000 would die from complications. 530 per 1,000,000 would develop non-lethal complications from touching the vaccine site. One example: If a newly vaccinated person touches the site and carries the virus on his hand to another part of the body, such as the eye, it can cause blindness. Source: CDC
The new AAP policy favors a “ring” approach — isolating those who develop smallpox and immunizing people around them — rather than giving shots before an attack to anyone who volunteers. A key concern about a “voluntary,” preventive plan is that immunized people develop a blister that can transmit the virus to others who haven’t volunteered for shots. “There is no such thing as a truly voluntary plan,” Baltimore says.
Routine smallpox vaccination ended in 1972. The disease has been eradicated, but fears persist that terrorists have obtained stocks of the virus.
Esw have wtimates on adverse reactions from the vaccine, which are based on studies in the 1960s, could be low because more Americans now have weak immune systems, Baltimore says. Those with weaker immune function are most likely to be harmed by the vaccine or from contact with immunized people.
Children pose special problems. The United States has stored vaccine that can be diluted and that will work for adults if there’s a mass immunization program. But the diluted dosage needed for children is unknown, Baltimore says.
The government has plans to test that vaccine on children in the Cincinnati and Los Angeles areas. But it’s unknown when or even if the study will start, says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Experts will testify on the risks and benefits of the study for kids at a public meeting in November called by the Department of Health and Human Services, Fauci says. The HHS secretary “will have to approve the trial,” he says.
Although some parents are worried, most aren’t clamoring for their kids to get smallpox shots, according to an informal USA TODAY check with children’s doctors. The scene is nothing like last year’s anthrax scare, when pediatricians were swamped with demands for antibiotics and smallpox vaccines.
“It’s not on their radar screen right now,” says pediatrician Garry Gardner of Darien, Ill. Loraine Stern, who treats middle-class families in Newhall, Calif., says: “Parents are concerned; they’re asking about it. But they’re not acting cuckoo like they were last fall.”
FAIR USE NOTICE: This may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.